Suchergebnisse - "Sifuentes-Osornio, Jose"

PubPharm (233)

1

Complete remission with histamine blocker in a patient with intractable hyperadrenergic postural orthostatic tachycardia syndrome secondary to long coronavirus disease syndrome

enthalten in: Journal of hypertension | 2024

von González-Alvarez, F. | Estañol, B. | González-Hermosillo, J. | +10

2

Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era : a propensity score-matched study

enthalten in: Therapeutic advances in infectious disease | 2024

von Rajme-López, S. | Martinez-Guerra, B. | Román-Montes, C. | +13

3

Cutaneous Infections by Geotrichum spp.

enthalten in: Current fungal infection reports | 2024

von Román-Montes, C. | Sifuentes-Osornio, J. | Martínez-Gamboa, A.

4

Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure

enthalten in: ResearchSquare.com | 2023

von Ordaz-Vázquez, A. | Torres-González, P. | Ferreyra-Reyes, L. | +6

5

The burden of antimicrobial resistance in the Americas in 2019 : a cross-country systematic analysis

enthalten in: Lancet regional health. Americas | 2023

von Antimicrobial Resistance Collaborators | Aguilar, G. | Swetschinski, L. | +98

ErratumIn: Lancet Reg Health Am. 2023 Nov 10;28:100632. - PMID 38033356

6

Safety and Tolerability of Six Months of Isoniazid or Three Months of Rifampicin for Tuberculosis Among Subjects With Diabetes Mellitus: A Randomized Trial

enthalten in: Preprints.org | 2023

von Tamez-Torres, K. | Mongua-Rodríguez, N. | Ferreyra-Reyes, L. | +12

7

Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus : A Randomized Trial

enthalten in: Microorganisms | 2023

von Tamez-Torres, K. | Mongua-Rodríguez, N. | Ferreyra-Reyes, L. | +12

8

enthalten in: Salud publica de Mexico | 2023

von Martínez-Duncker R, D. | Urzúa-González, A. | Aguilera-Mora, L. | +19

9

Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Rivera-Villegas, H. | Martinez-Guerra, B. | Garcia-Couturier, R. | +16

10

Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Solís-Huerta, F. | Martinez-Guerra, B. | Roman-Montes, C. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]